XML 82 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 11. Goodwill and Other Intangibles
12 Months Ended
Feb. 02, 2013
Intangible Assets Disclosure [Text Block]
11.          Goodwill and other intangibles

The table below presents the balances of our intangible assets (in thousands):

   
February 2, 2013
   
January 28, 2012
 
                 
Acquired intangible assets
  $ 77,146     $ 75,978  
Purchased IP
    23,450       22,204  
Total
    100,596       98,182  
Accumulated amortization
    (64,023 )     (52,526 )
Intangible assets, net
  $ 36,573     $ 45,656  

Impairment of intangible assets

We assess the carrying value of our long-lived assets whenever events or changes in circumstances indicate that the carrying value of these assets may not be recoverable.

As of October 29, 2011, we performed a review of the carrying value of our intangible assets due to continued reductions in our profitability and sales forecasts, and negative cash flows from operations. In performing this review, we developed a forecast of the total undiscounted cash flow expected to be generated by each acquired intangible asset group and compared the result to the carrying value. The results of this review indicated that two of our intangible asset groups, consisting primarily of certain developed technology and customer relationship intangibles related to our CopperGate acquisition, were not fully recoverable.  Therefore, we performed the second step of the analysis by developing a discounted cash flow analysis for each of the individual identifiable assets in these two groups to determine the amount of impairment. Our analysis resulted in an impairment charge of $55.1 million in fiscal 2012.

As of February 2, 2013, due to continued reductions in our profitability, negative cash flows from operations and our restructuring measures adopted in fiscal 2013, we performed an impairment review of our intangible assets.  The results of this review indicated that certain purchased IP incorporated into discontinued products and products in development were impaired; as a result, we recorded an impairment charge for purchased IP of $8.2 million.  In addition, we recorded an impairment charge for certain software, equipment and leasehold improvements and prepaid licenses associated with such discontinued products of $2.6 million and $0.4 million, respectively.  The impairment related to developed products of $4.6 million was recorded in cost of revenue and the impairment related to products in development of $6.6 million was recorded in operating expenses in the accompanying consolidated statements of operations in fiscal 2013.

Impairment of goodwill and in-process research and development
We review goodwill for impairment annually, as of the last day of our fiscal year, and whenever events or changes in circumstances indicate the carrying value may not be recoverable.  IP R&D is not subject to amortization and is tested for impairment annually or more frequently, if events or changes in circumstances indicate that the asset might be impaired.

As of October 29, 2011, we concluded that an interim review of the carrying value of our goodwill and IP R&D should be performed due to continued reductions in our profitability, sales forecasts and market capitalization. In performing this review, we used both the income and the market valuation methodologies. In applying the income approach, we developed a forecast of the discounted cash flows expected to be generated by our operating unit and in applying the market approach, we utilized the current value of our publically traded common stock adjusted for a control premium. The result of this review showed that the fair value of our reporting unit was less than its net book value and, therefore, indicated a possible impairment. Therefore, we performed the second step of the analysis by allocating the fair value of our reporting unit to all of its assets and liabilities on a fair value basis to determine the amount of the impairment. As a result of this analysis, we determined that the carrying value of our goodwill and IP R&D was fully impaired, which resulted in an impairment charge of $45.1 million and $11.1 million, respectively, in fiscal 2012.  Subsequent to January 28, 2012, we have not capitalized any goodwill or IP R&D.

Intangible assets, subject to amortization, were as follows (in thousands, except for years): 

   
February 2, 2013
 
   
Gross Value
   
Impairment
   
Accumulated Amortization and Effect of Currency Translation
   
Net Value
   
Weighted Average Remaining Amortization Period (Years)
 
Acquired intangible assets:
                             
Developed technology
  $ 76,995     $ (24,614 )   $ (34,923 )   $ 17,458     3.6  
Customer relationships
    51,174       (30,486 )     (16,252 )     4,436     3.6  
Trademarks
    2,677       -       (1,982 )     695     5.9  
Non-compete agreements
    1,400       -       (1,400 )     -        
Purchased IP - amortizing
    22,866       (5,516 )     (9,466 )     7,884     2.4  
Total amortizing
    155,112       (60,616 )     (64,023 )     30,473     3.4  
Purchased IP - not yet deployed
    8,778       (2,678 )     -       6,100        
In-process research and development
    11,070       (11,070 )     -       -        
Total intangibles
  $ 174,960     $ (74,364 )   $ (64,023 )   $ 36,573        

   
January 28, 2012
 
   
Gross Value
   
Impairment
   
Accumulated Amortization and Effect of Currency Translation
   
Net Value
   
Weighted Average Remaining Amortization Period (Years)
 
Acquired intangible assets:
                             
Developed technology
  $ 75,827     $ (24,614 )   $ (28,455 )   $ 22,758     4.7  
Customer relationships
    51,174       (30,486 )     (14,966 )     5,722     4.8  
Trademarks
    2,677       -       (1,805 )     872     6.6  
Non-compete agreements
    1,400       -       (1,400 )     -        
Purchased IP - amortizing
    8,395       -       (5,900 )     2,495     1.9  
Total amortizing
    139,473       (55,100 )     (52,526 )     31,847     4.8  
Purchased IP - not yet deployed
    13,809       -       -       13,809        
In-process research and development
    11,070       (11,070 )     -       -        
Total intangibles
  $ 164,352     $ (66,170 )   $ (52,526 )   $ 45,656        

Amortization expense related to intangible assets was $11.6 million, $18.7 million and $19.6 million for fiscal 2013, 2012 and 2011, respectively.  As of February 2, 2013, we expect the amortization expense in future periods to be as follows (in thousands):

Fiscal years
 
Purchased IP-Amortizing
   
Developed Technology
   
Trademarks
   
Customer Relationships
   
Total
 
                                         
2014
  $ 3,438     $ 5,767     $ 119     $ 1,265     $ 10,589  
2015
    3,095       4,282       118       1,265       8,760  
2016
    1,351       3,957       118       1,109       6,535  
2017
    -       2,957       118       797       3,872  
2018
    -       495       118       -       613  
Thereafter
    -       -       104       -       104  
Total
  $ 7,884     $ 17,458     $ 695     $ 4,436     $ 30,473